Gait pattern in Duchenne muscular dystrophy

Gait and Posture

Volumn 29, Issue 1, 2009, Pages 36-41

  D'Angelo, Maria Grazia ^a   Berti, Matteo ^a   Piccinini, Luigi ^a   Romei, Marianna ^a   Guglieri, Michela ^a,b   Bonato, Sara ^a   Degrate, Alessandro ^a   Turconi, Anna Carla ^a   Bresolin, Nereo ^a,b  

^a SCIENTIFIC INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Ambulation; Biomechanics; Duchenne muscular dystrophy; Gait Analysis; Steroids treatment

Indexed keywords

STEROID;

AGED; ARTICLE; BIOMECHANICS; CLINICAL ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; GAIT; HUMAN; KNEE FUNCTION; MALE; MOBILIZATION; PRIORITY JOURNAL;

ADRENAL CORTEX HORMONES; BIOMECHANICS; CASE-CONTROL STUDIES; CHILD; GAIT; HUMANS; LOWER EXTREMITY; MALE; MUSCULAR DYSTROPHY, DUCHENNE; STATISTICS, NONPARAMETRIC;

EID: 57649150076     PISSN: 09666362     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.gaitpost.2008.06.002     Document Type: Article

References (29)

1. Brooke M.H., Fenichel G.M., Griggs R.C., et al. Clinical investigation in Duchenne dystrophy: determination of the "power" of therapeutic trials based on the natural history. Muscle Nerve 6 (1983) 91-103
2. Brooke M.H., Fenichel G.M., Griggs R.C., et al. Duchenne dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology 39 (1989) 475-481
3. Bushby K, Muntoni F, Urtizberea A, et al. Report on the 124th ENMC International Workshop. Treatment of Duchenne muscular dystrophy; defining the gold standards of management in the use of corticosteroids. Naarden, The Netherlands. April 2-4, 2004 Neuromuscul. Disord. September 2004; 14(8-9):526-34.
4. Markham A., and Bryson H.M. Deflazacort: a review of its pharmacological properties and therapeutic efficacy. Drugs (1995) 317-333
5. Angelini C., Pegoraro E., Turella E., et al. Deflazacort in Duchenne dystrophy: study of long-term effect. Muscle Nerve 17 (1994) 386-391
6. Biggar W.D., Gingras M., Fehlings D.L., et al. Deflazacort treatment of Duchenne dystrophy. J Pediatr 138 (2001) 45-50
7. DeSilva S., Drachman D.B., Mellits D., and Kuncl R.W. Prednisone treatment in Duchenne dystrophy. Long-term benefit. Arch Neurol 44 (1987) 818-822
8. Manzur A.Y., Kuntzer T., Pike M., and Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev 1 (2008) CD003725
9. Fenichel G.M., Florence J.M., Pestronk A., et al. Long-term benefit from prednisone therapy in Duchenne dystrophy. Neurology 41 (1991) 1874-1877
10. Griggs R.C., Moxley III R.T., Mendell J.R., et al. Duchenne dystrophy: randomized, controlled trial of prednisone (18 months) and azathioprine (12 months). Neurology 43 (1993) 520-527
11. Griggs R.C., Moxley III R.T., Mendell J.R., et al. Prednisone in Duchenne dystrophy: a randomized, controlled trial defining the time course and dose response, clinical investigation of duchenne dystrophy group. Arch Neurol 48 (1991) 383-388
12. Jacobs S.C., Bootsma A.L., Willems P.W., et al. Prednisone can protect against exercise-induced muscle damage. J Neurol 243 (1996) 410-416
13. Khan M.A. Corticosteroid therapy in Duchenne dystrophy. J Neurol Sci 120 (1993) 8-14
14. Kissel J.T., Burrow K.L., Rammohan K.W., et al. Mononuclear cell analysis of muscle biopsies in prednisone-treated and untreated Duchenne dystrophy. CIDD Study Group. Neurology 41 (1991) 667-672
15. Mendell J.R., Moxley III R.T., Griggs R.C.W., et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med 320 (1989) 1592-1597
16. Merlini L., Cicognani A., Malaspina E., et al. Early prednisone treatment in Duchenne dystrophy. Muscle Nerve 27 (2003) 222-227
17. Schara U., Mortier J., and Mortier W. Long-term steroid therapy in Duchenne dystrophy-positive results versus side effects. J Clin Neuromuscul Dis 2 (2001) 179-183
18. Wong B.L., and Christopher C. Corticosteroids in Duchenne dystrophy: a reappraisal. J Child Neurol 17 (2002) 183-190
19. Hsu J.D., and Furumasu J. Gait and posture changes in the Duchenne muscular dystrophy child. Clin Orthop Relat Res 288 March (1993) 122-125
20. Sutherland D.H., Olshen R., Cooper L., et al. The pathomechanics of gait in Duchenne muscular dystrophy. Dev Med Child Neurol 23 (1981) 3-22
21. Patte K., Pelissier J., Benaim C., et al. Gait analysis in Duchenne muscular dystrophy. Ann Readapt Med Phys 43 (2000) 58
22. Armand S., Mercier M., Watelain E., et al. A comparison of gait in spinal muscular atrophy, type II and Duchenne muscular dystrophy. Gait Posture 21 June (4) (2005) 369-378
23. Moreno Izco F., Mendioroz Iriarte M., Poza Aldea J.J., et al. Analysis of gait and movement of upper limbs in muscular dystrophies. Neurologia 20 September (7) (2005) 341-348
24. Griggs R.C., and Bushby K. Continued need for caution in the diagnosis of Duchenne muscular dystrophy. Neurology 64 May (9) (2005) 1498-1499
25. Medical Research Council. Aids to the investigation of peripheral nerve injuries (1976), Her Majesty Stationery Office, London, England
26. Ferrigno G., Pedotti A. ELITE: a digital dedicated hardware system for movement analysis via real-time TV signal processing, in IEEE Transactions on Biomedical Engineering, BME; 32, 1985. p. 943-50.
27. Davis R.B., Ounpuu S., Tybursky D., and Gage J.R. A gait analysis data collection and reduction technique. Hum Mov Sci 10 (1991) 575-587
28. Benedetti M.G., Catani F., Leardini A., et al. Data management in gait analysis for clinical applications. Clin Biomech 13 (1998) 204-215
29. Levene H. In: Olkin I., et al. (Ed). Contributions to probability and statistics: essays in honor of harold hotelling (1960), Stanford University Press, Stanford, CA 278-292